Conference Dates
June 12 – 17, 2022
Abstract
Please click Additional File below for the presentation.
Recommended Citation
Nicolas Havelange, "Disease X development and 100 days initiative" in "Vaccine Technology VIII", Tarit Mukhopadhyay, Merck Research Laboratories, USA; Charles Lutsch, Sanofi Pasteur, France; Linda Hwee-Lin Lua, University of Queensland, Australia; Francesc Godia, Universitat Autònoma de Barcelona, Spain Eds, ECI Symposium Series, (2022). https://dc.engconfintl.org/vaccine_viii/40
COinS